Malaysia Pharmaceutical Industry to Go Global

14 Oct 2021   |  Malaysia

Malaysia's pharmaceutical industry is expected to grow by 4 to 6 percent at the end of 2021. The increasing number is due to the rising pharmaceutical use for COVID-19 treatment and vaccine inoculation, benefitting massively for vaccine manufacturers such as Pfizer, AstraZeneca, and Johnson & Johnson. Pfizer informed a record of USD 26 billion global revenue this year.

Active Pharmaceutical Ecosystem

Regardless of the COVID-19's presence, Malaysia is already home to an actively changing pharmaceutical landscape. With robust research and developments and the manufacturing of drugs innovations, the country has received numerous investments to drive the pharmaceutical industry forward. Moreover, the Malaysian government highly supports the domestic pharmaceutical market growth through innovative regulatory frameworks regulated by the National Pharmaceutical Regulatory Agency (NPRA) under the umbrella of the Ministry of Health Malaysia.

The nation's pharmaceutical market share comprises two top categories, local pharmaceutical companies, and research-based multinational enterprises. The two differ significantly on their core businesses: the local pharmaceutical companies dedicate their focus on traditional medicines, vitamins, supplements, and over-the-counter (OTC) drugs manufacturing. In contrast, research-based multinational enterprises are responsible for access to international standards drugs with proven efficacy and quality that require extensive research and development.

Pharmaceutical Industry Growth by Category

Pharmaceutical

Product-wise, the Malaysian pharmaceutical industry is divided into two types: ethical and self-care products. Ethical products consist of vaccines, innovative medicines, and generic drugs, while self-care products include OTC medicines, supplements, and personal care goods. The two categories have recently experienced a surge in demand stemming from urbanization-induced medical conditions alongside the prevalence of COVID-19. The increasing health literacy and disposable income also allowed Malaysian citizens to consume more self-care products, eventually leading to companies providing a wide array of products.

Entering the Global Market

Today, Malaysian domestic pharmaceutical companies enjoy buoyant investments to charge the industry's growth. Pharmaniaga, for example, has recorded a 127 percent increase in gross merchandise value since given a mandate from the country's government to take part in vaccine distribution in July 2020. The company operates under license from Sinovac for its technology and production know-how. The technology transfer done by Sinovac and Pharmaniaga would benefit both parties and the overall pharmaceutical industry to catch up with relevant standards and increase production efficiency.

The joint venture would bring Pharmaniaga's earnings to around RM 25.5 million at the end of 2021, positioning the company to become the leading pharmaceutical enterprise in the country.

Duopharma Biotech Bhd, a Malaysian pharmaceutical distributor, also jumpstart its topline core activities by identifying a similar project. The company is in talks with a Russian-based vaccine producer to massively manufacture the COVID-19 vaccine in Malaysia, planning to provide over 60 million doses per year after the deal establishment. Based on the deal timeline, Duopharma sets the plan to launch its vaccine production to start in the third quarter of 2021.

The venture of Duopharma and Pharmaniaga shows the start of Malaysia's pharmaceutical industry to enter the global landscape, poising other players to follow the trailblazing path of domestic manufacturing by benchmarking from the globally proven models existing in the market.

Read Other Insights
Pharmaceutical
Malaysia Pharmaceutical Industry to Go Global

Malaysia’s pharmaceutical industry is expected to grow significantly, as domestic companies establish knowledge transfer from globally proven benchmarks

Fintech
The Vibrant Malaysia Fintech Ecosystem

Malaysia experiences a boom in the fintech industry with layered opportunities and a large market share landscape.

Malaysian Islamic Financial
The Rapid Growth of Malaysian Islamic Financial Sector

The Islamic financial system in Malaysia had shown a positive resilience during the pandemic, reaching over 37 percent of the country's banking sector.

Malaysia to Accelerate the Implementation of Digital Economy
Malaysia to Accelerate the Implementation of Digital Economy

The digital economy in Malaysia would allow economic activities to leverage information and technology as the essential element in production and business.